Results 221 to 230 of about 21,252 (310)

Plasma donation rates and infection risk: A multicentre observational study in Denmark

open access: yesVox Sanguinis, EarlyView.
Abstract Background and Objectives The demand for plasma‐derived medicinal products underscores the need to assess health effects of plasma donation. This study examines the association between plasma donation rates and infection risk in a country with voluntary, non‐remunerated donation.
Kathrine Agergård Kaspersen   +18 more
wiley   +1 more source

Identification of Crucial Drug Targets and Pathways to Reprogram Drug Resistance Through Epigenetic Modulation in Advanced Lung Cancer Using Integrated Bioinformatics Approach

open access: yesComputational and Systems Oncology, Volume 6, Issue 1, December 2026.
ABSTRACT Resistance to chemotherapy, which is demonstrated in almost every patient with advanced‐stage lung cancer (ALC), underscores an urgent need to unravel the underlying molecular mechanisms and identify novel strategies to overcome drug resistance. In the present study, an attempt was made to identify epigenetic targets and modulators that can be
Okibur Rahman   +2 more
wiley   +1 more source

Sensitive Period Analysis of Adulthood BMI and Cancer Risk: An Individual Participant Data Meta‐Analysis of Over 720,000 Participants in the ABACus 2 Consortium

open access: yesInternational Journal of Cancer, Volume 159, Issue 4, Page 960-972, 15 August 2026.
Over a dozen cancers have been associated with excess body mass index, primarily in mid‐to‐late adulthood. Whether obesity‐related cancer risk differs across adulthood remains unclear. Using the Sensitive Periods Model and super‐landmarking approaches, this study found that higher BMI increased obesity‐related cancer risk across ages 30–65.
Nadin K. Hawwash   +13 more
wiley   +1 more source

"A Tangible Gift of Intangible Value": The Process of Legacy Creation Among Older Adults. [PDF]

open access: yesJ Appl Gerontol
Neller SA   +5 more
europepmc   +1 more source

Prediction of dose reductions and impact of reduced starting doses of CDK4/6i on effectiveness in HR‐positive/HER2‐negative metastatic breast cancer: Real‐world data from the OPAL registry

open access: yesInternational Journal of Cancer, Volume 159, Issue 1, Page 244-256, 1 July 2026.
What's New? Balancing efficacy and tolerability is challenging in oncology, as standard dosing often prioritizes maximum tolerated doses over other patient needs. Here, the authors developed a predictive index to identify patients with increased probability of dose reduction in metastatic breast cancer and compared the real‐world effectiveness of ...
Patrick Marschner   +19 more
wiley   +1 more source

Infection-Induced Telomere Length Variation: Insights into Pathogenesis of Koala Retrovirus. [PDF]

open access: yesViruses
Cheung HM   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy